€43.82
0.83% day before yesterday
Amsterdam, Dec 27, 05:35 pm CET
ISIN
NL0006144495
Symbol
REN
Index
AEX
Sector
Industry

RELX Stock price

€43.82
-0.80 1.79% 1M
+0.68 1.58% 6M
+8.00 22.33% YTD
+8.23 23.12% 1Y
+15.64 55.50% 3Y
+21.27 94.32% 5Y
+31.02 242.46% 10Y
Amsterdam, Closing price Fri, Dec 27 2024
+0.36 0.83%
ISIN
NL0006144495
Symbol
REN
Index
AEX
Sector
Industry

Key metrics

Market capitalization €81.32b
Enterprise Value €89.33b
P/E (TTM) P/E ratio 37.36
EV/FCF (TTM) EV/FCF 30.08
EV/Sales (TTM) EV/Sales 8.25
P/S ratio (TTM) P/S ratio 7.51
P/B ratio (TTM) P/B ratio 21.55
Dividend yield 1.60%
Last dividend (FY24) €0.70
Revenue growth (TTM) Revenue growth 3.68%
Revenue (TTM) Revenue €10.83b
EBIT (operating result TTM) EBIT €3.26b
Free Cash Flow (TTM) Free Cash Flow €2.97b
EPS (TTM) EPS €1.17
P/E forward 32.86
P/S forward 7.09
EV/Sales forward 7.79
Show more

Is RELX a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

RELX Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a RELX forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a RELX forecast:

Buy
100%

Financial data from RELX

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
10,831 10,831
4% 4%
100%
- Direct Costs 4,069 4,069
0% 0%
38%
6,762 6,762
6% 6%
62%
- Selling and Administrative Expenses 2,581 2,581
4% 4%
24%
- Research and Development Expense - -
-
-
4,181 4,181
7% 7%
39%
- Depreciation and Amortization 920 920
0% 0%
8%
EBIT (Operating Income) EBIT 3,261 3,261
10% 10%
30%
Net Profit 2,203 2,203
10% 10%
20%

In millions EUR.

Don't miss a Thing! We will send you all news about RELX directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity. The Risk & Business Analytics segment provides customers with solutions and decision tools that combine public and industry specific content with advanced technology and analytics to assist them in evaluating and predicting risk and enhancing operational efficiency. The Legal segment is a global provider of legal, regulatory and business information and analytics that helps customers increase productivity, improve decision-making and outcomes and advance the rule of law around the world. The Exhibitions segment is an event business, enhancing the effect of face-to-face through data and digital tools. The company was founded by Albert Edward Reed in 1894 and is headquartered in London, the United Kingdom.

Head office Netherlands
CEO Erik Engstrom
Employees 36,500
Founded 1903
Website www.relx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today